Thanks - the company is Cynata ASX CYP but a long long way back in terms of where it is at. Have a phase 1 trial with preliminary results that are positive as you would expect. But a long long way to go. Mesoblast is going to beat it to market by many, many years that is if Cynata ever gets it there.
Cheers
- Forums
- ASX - By Stock
- MSB
- MSB trading
MSB
mesoblast limited
Add to My Watchlist
12.3%
!
$2.43
MSB trading, page-402
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
